XBiotech (XBIT) Other Working Capital Changes (2014 - 2025)

XBiotech has reported Other Working Capital Changes for 2 years, with the latest figure at -$1.5 million in Q2 2020.

• On a quarterly basis, Other Working Capital Changes fell 21.43% year-over-year to -$17000.0 in Q4 2025; TTM through Dec 2025 was $10000.0, a 96.31% decrease from a year earlier, with the FY2025 full-year figure at $10000.0, down 96.31% from the prior year.
• Other Working Capital Changes was -$17000.0 for Q4 2025 at XBiotech, up from -$254000.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was $2.0 million in Q1 2021, with the low at -$2.2 million in Q2 2021.
• Average Other Working Capital Changes over 5 years is $22950.0, with a median of -$10500.0 recorded in 2021.
• The sharpest annual moves came in 2022 and 2023: Other Working Capital Changes soared 1185.71% in 2022, then sank 490.0% in 2023.
• Over 5 years, Other Working Capital Changes stood at $559000.0 in 2021, then plunged by 103.58% to -$20000.0 in 2022, then tumbled by 490.0% to -$118000.0 in 2023, then jumped by 88.14% to -$14000.0 in 2024, then declined by 21.43% to -$17000.0 in 2025.
• The last three Other Working Capital Changes figures came in at -$17000.0 (Q4 2025), -$254000.0 (Q3 2025), and $163000.0 (Q2 2025), per Business Quant data.